Doctor Robert Stoehr

University Hospital Frankfurt, Frankfurt (Germany)

Follow

Contributor content

The influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification the IRIVASC-trial

Presentation

The influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification the IRIVASC-trial

ESC 365 is supported by

novartis

Explore sponsored resources